| Bristol Myers Squibb (BMY) |
United States |
$143.047B |
10.20 |
| Amgen (AMGN) |
United States |
$128.345B |
13.42 |
| CSL (CSLLY) |
Australia |
$107.136B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$75.525B |
10.04 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$56.298B |
26.18 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$54.004B |
19.16 |
| Illumina (ILMN) |
United States |
$44.622B |
61.37 |
| Moderna (MRNA) |
United States |
$39.001B |
0.00 |
| Biogen (BIIB) |
United States |
$37.318B |
6.63 |
| Seagen (SGEN) |
United States |
$29.684B |
78.39 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$26.942B |
10.73 |
| BeiGene (BGNE) |
Cayman Islands |
$23.260B |
0.00 |
| Genmab (GMAB) |
Denmark |
$23.092B |
27.31 |
| BioNTech SE (BNTX) |
Germany |
$23.049B |
0.00 |
| Genmab (GNMSF) |
Denmark |
$21.857B |
5.03 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$18.127B |
0.00 |
| Incyte (INCY) |
United States |
$17.682B |
0.00 |
| Exact Sciences (EXAS) |
United States |
$17.639B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$15.572B |
59.05 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$15.238B |
21.78 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$14.599B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$14.152B |
93.93 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$12.329B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$11.692B |
74.77 |
| Guardant Health (GH) |
United States |
$11.297B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$11.233B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$10.662B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$10.604B |
23.88 |
| Repligen (RGEN) |
United States |
$9.427B |
133.69 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$8.699B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$8.508B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$8.072B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$7.771B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$7.317B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$7.257B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$6.874B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$6.156B |
0.00 |
| Novavax (NVAX) |
United States |
$6.069B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$5.871B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$5.759B |
19.07 |
| Exelixis (EXEL) |
United States |
$5.715B |
38.38 |
| Reata Pharmaceuticals (RETA) |
United States |
$5.572B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$5.501B |
254.31 |
| SWEDISH ORP BIO (BIOVF) |
Sweden |
$5.271B |
14.40 |
| NeoGenomics (NEO) |
United States |
$5.009B |
1503.67 |
| Fate Therapeutics (FATE) |
United States |
$4.822B |
0.00 |
| China Biologic Products (CBPO) |
China |
$4.673B |
30.29 |
| Twist Bioscience (TWST) |
United States |
$4.653B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$4.196B |
13.77 |
| Insmed (INSM) |
United States |
$4.049B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$3.803B |
0.00 |
| Legend Biotech (LEGN) |
United States |
$3.637B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$3.531B |
127.81 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$3.516B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$3.465B |
0.00 |
| Eidos Therapeutics (EIDX) |
United States |
$3.326B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$2.924B |
28.70 |
| Bluebird Bio (BLUE) |
United States |
$2.830B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$2.800B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$2.692B |
0.00 |
| Beam Therapeutics (BEAM) |
United States |
$2.409B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$2.189B |
0.00 |
| I-Mab (IMAB) |
China |
$2.120B |
0.00 |
| UniQure (QURE) |
Netherlands |
$2.067B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$2.057B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$2.045B |
0.00 |
| Viela Bio (VIE) |
United States |
$1.997B |
0.00 |
| Mesoblast (MESO) |
Australia |
$1.964B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$1.921B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$1.809B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$1.783B |
0.00 |
| Amarin (AMRN) |
Ireland |
$1.752B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.723B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$1.720B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$1.650B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$1.647B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$1.607B |
13.30 |
| Revance Therapeutics (RVNC) |
United States |
$1.558B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$1.551B |
0.00 |
| Alcobra (ARCT) |
United States |
$1.473B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$1.436B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.425B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.410B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$1.403B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$1.391B |
36.05 |
| Adverum Biotechnologies (ADVM) |
United States |
$1.385B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.347B |
8.90 |
| REGENXBIO (RGNX) |
United States |
$1.344B |
0.00 |
| Athenex (ATNX) |
United States |
$1.296B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.287B |
0.00 |
| Heska (HSKA) |
United States |
$1.219B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$1.201B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.199B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$1.192B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$1.167B |
0.00 |
| Precigen (PGEN) |
United States |
$1.128B |
0.00 |
| Genetron Holdings (GTH) |
China |
$1.081B |
0.00 |
| Codexis (CDXS) |
United States |
$1.061B |
0.00 |
| Vericel (VCEL) |
United States |
$1.053B |
0.00 |
| Alector (ALEC) |
United States |
$1.048B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$1.044B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$1.022B |
0.00 |
| Morphic Holding (MORF) |
United States |
$0.975B |
0.00 |
| Arvinas (ARVN) |
United States |
$0.967B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.958B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.907B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.903B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$0.894B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.880B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$0.876B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.850B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.835B |
0.00 |
| NantKwest (NK) |
United States |
$0.824B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.755B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.753B |
17.19 |
| MiMedx (MDXG) |
United States |
$0.722B |
0.00 |
| MannKind (MNKD) |
United States |
$0.712B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.702B |
0.00 |
| Agenus (AGEN) |
United States |
$0.694B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.691B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.686B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.682B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.678B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.675B |
34.28 |
| AnaptysBio (ANAB) |
United States |
$0.674B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.657B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.640B |
43.13 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.619B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.616B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.603B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.598B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.569B |
0.00 |
| Geron (GERN) |
United States |
$0.562B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.555B |
75.08 |
| IVERIC Bio (ISEE) |
United States |
$0.554B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.509B |
0.00 |
| Aquinox Pharmaceuticals (NLTX) |
United States |
$0.508B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.497B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.476B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.474B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.467B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.457B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.456B |
0.00 |
| Amryt Pharma (AMYT) |
United Kingdom |
$0.445B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.444B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.443B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.439B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.433B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.433B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.432B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.419B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.408B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.408B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.403B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.391B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.388B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.386B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.377B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.375B |
17.67 |
| Cue Biopharma (CUE) |
United States |
$0.375B |
0.00 |
| Trevena (TRVN) |
United States |
$0.372B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.361B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.361B |
9.18 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.360B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.359B |
0.00 |
| XOMA (XOMA) |
United States |
$0.358B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.351B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.341B |
0.00 |
| Athersys (ATHX) |
United States |
$0.312B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.305B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.302B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.297B |
13.92 |
| PDL BioPharma (PDLI) |
United States |
$0.286B |
0.00 |
| NextCure (NXTC) |
United States |
$0.280B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.278B |
0.00 |
| Verastem (VSTM) |
United States |
$0.268B |
0.00 |
| IBio (IBIO) |
United States |
$0.268B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.264B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.255B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.243B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.241B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.236B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.234B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.209B |
0.00 |
| Lineage Cell Therapeutics (LCTX) |
United States |
$0.192B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.186B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.186B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.185B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.185B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.185B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.182B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.179B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.178B |
0.00 |
| Cerecor (CERC) |
United States |
$0.178B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.176B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.175B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.170B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.164B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.164B |
0.00 |
| VolitionRX (VNRX) |
United States |
$0.162B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.162B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.160B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.159B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.158B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.157B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.157B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.147B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.137B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.137B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.137B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.133B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.133B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.130B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.126B |
0.00 |
| Exicure (XCUR) |
United States |
$0.122B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.118B |
245.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.117B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.117B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.116B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.113B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.112B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.112B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.111B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$0.107B |
0.00 |
| PhaseBio Pharaceuticals (PHAS) |
United States |
$0.105B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.102B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.101B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.098B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.098B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.095B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.095B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.094B |
0.00 |
| Prometic Life Sciences (LMNL) |
Canada |
$0.094B |
0.00 |
| AIT Therapeutics (XAIR) |
United States |
$0.092B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.089B |
0.00 |
| Ecology Coatings (ABVC) |
United States |
$0.083B |
0.00 |
| Curis (CRIS) |
United States |
$0.081B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.080B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.076B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.075B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.075B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.074B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.072B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.069B |
0.00 |
| Stealth BioTherapeutics (MITO) |
United States |
$0.069B |
33.00 |
| Adocia (ADOCY) |
France |
$0.067B |
0.00 |
| MiRagen Therapeutics (MGEN) |
United States |
$0.065B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.064B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.062B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.062B |
0.00 |
| Armata Pharmaceuticals (ARMP) |
United States |
$0.059B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.058B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.057B |
0.00 |
| Appili Therapeutics (APLIF) |
Canada |
$0.053B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.053B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.051B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.051B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.050B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.049B |
0.00 |
| Seelos Therapeutics (SEEL) |
United States |
$0.046B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.044B |
0.00 |
| CollPlant Holdings (CLGN) |
Israel |
$0.044B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.042B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.041B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.040B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.040B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.039B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.036B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.036B |
0.00 |
| Chanticleer Holdings (SONN) |
United States |
$0.035B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.033B |
0.00 |
| OvaScience (MLND) |
United States |
$0.032B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.029B |
0.00 |
| PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.029B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.028B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.026B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.025B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.024B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.023B |
0.00 |
| Celsion (CLSN) |
United States |
$0.020B |
0.00 |
| Cesca Therapeutics (THMO) |
United States |
$0.020B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.019B |
0.00 |
| Spherix (AIKI) |
United States |
$0.018B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.017B |
0.00 |
| Invo BioScience (INVO) |
United States |
$0.015B |
0.00 |
| BioPharmX (TMBR) |
United States |
$0.013B |
0.00 |
| MedAvail Holdings (MDVL) |
United States |
$0.012B |
0.00 |
| Neuralstem (SNCA) |
United States |
$0.011B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.010B |
0.00 |
| Benitec Biopharma (BNTC) |
Australia |
$0.003B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
| Osmotica Pharmaceuticals (OSMT) |
United States |
$0.000B |
0.00 |
| Zai Lab (ZLAB) |
China |
$0.000B |
0.00 |
